OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
3.780
+0.260 (7.39%)
At close: Mar 13, 2026, 4:00 PM EDT
3.800
+0.020 (0.53%)
After-hours: Mar 13, 2026, 7:43 PM EDT
OnKure Therapeutics Market Cap
OnKure Therapeutics has a market cap or net worth of $51.69 million as of March 13, 2026. Its market cap has decreased by -20.76% in one year.
Market Cap
51.69M
Enterprise Value
-6.81M
1-Year Change
-20.76%
Ranking
Category
Stock Price
$3.78
Market Cap Chart
Since October 7, 2024, OnKure Therapeutics's market cap has decreased from $248.78M to $51.69M, a decrease of -79.22%. That is a compound annual growth rate of -66.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 51.69M | 31.55% |
| Dec 31, 2025 | 39.29M | -65.75% |
| Dec 31, 2024 | 114.72M | -53.89% |
| Oct 7, 2024 | 248.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Metagenomi Therapeutics | 54.93M |
| OS Therapies | 54.58M |
| Lipocine | 53.58M |
| Estrella Immunopharma | 52.96M |
| NRx Pharmaceuticals | 52.26M |
| Acrivon Therapeutics | 51.12M |
| Kezar Life Sciences | 50.16M |
| Edesa Biotech | 49.76M |